1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Dementia, Mild: new trials by email Literature Review of Dementia, Mild trials Research Report on Dementia, Mild
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease ALZ-101, Placebo - Alzheimer Disease, Dementia Alzheimers | Phase 1 | Completed | Alzinova AB | 33 | 2021-09-30 | 2025-01-31 |
Alzheimer Disease (1) · Dementia (1) · Lymphoma, Follicular (1)
Brain Diseases (1) · Central Nervous System Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Mental Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Nervous System Diseases (1) · Neurocognitive Disorders (1) · Neurodegenerative Diseases (1)
Alzinova AB (1)
Finland (1)
Juha Rinne, MD (1)
2019 (1)